Aurinia PharmaceuticalsAUPH
那斯達克 · USD
14.02
-0.05
(-0.36%)
收盤 03/21 03:59 (UTC+8)
03/21 03:59 (UTC+8)
Aurinia PharmaceuticalsAUPH
14.02
-0.05
(-0.36%)
財務數據
損益表
- 0.55
- 0.45
- 0.50
- 0.57
- 0.68
- 0.60
- 0.62
- 0.70
- 0.73
- 0.77
- 31.38
- -17.28
- 11.55
- 13.70
- 18.50
- -11.66
- 4.34
- 12.08
- 4.94
- 4.96
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 77,114 | 73,468 | 70,008 | 62,465 | 59,867 | 67,771 | 57,192 | 50,303 | 45,095 | 54,515 |
營業成本 | 8,799 | 8,177 | 7,115 | 8,574 | 5,552 | 6,035 | 8,909 | 7,752 | 5,395 | 6,769 |
營業毛利 | 68,315 | 65,291 | 62,893 | 53,891 | 54,315 | 61,736 | 48,283 | 42,551 | 39,700 | 47,746 |
營業費用 | 35,076 | 35,546 | 42,810 | - | 55,984 | 49,988 | 49,796 | 55,804 | 69,374 | 64,009 |
研發費用 | 10,895 | 8,435 | 7,432 | 5,743 | 8,107 | 3,047 | 4,080 | 5,551 | 10,228 | 13,605 |
推銷及管理費用 | 24,181 | 27,111 | 35,264 | 24,768 | 32,526 | 46,941 | 44,644 | 43,570 | 59,146 | 50,404 |
非經常性項目費用 | - | - | 114 | 1,533 | 15,351 | - | 1,072 | 6,683 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 33,239 | 29,745 | 20,083 | 21,847 | -1,669 | 11,748 | -1,513 | -13,253 | -29,674 | -16,263 |
其他收入及費用 | 3,498 | 3,316 | 3,190 | 3,569 | 3,988 | 4,267 | 4,189 | 4,526 | 4,568 | 4,514 |
利息費用 | 1,047 | 1,099 | 1,117 | 1,067 | 1,146 | 1,208 | 1,198 | 1,283 | 1,310 | 1,400 |
稅前純益 | 35,690 | 31,962 | 22,156 | 24,349 | 1,173 | 14,807 | 1,478 | -10,010 | -26,416 | -13,149 |
所得稅 | -175,104 | 411 | 643 | 1,005 | -256 | 457 | 756 | 739 | 459 | 298 |
稅後純益 | 210,794 | 31,551 | 21,513 | 23,344 | 1,429 | 14,350 | 722 | -10,749 | -26,875 | -13,447 |
基本每股稅後盈餘(元) | 1.60 | 0.24 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | - | -0.09 |
稀釋每股稅後盈餘(元) | 1.52 | 0.23 | 0.16 | 0.16 | 0.01 | 0.10 | 0.00 | -0.07 | -0.18 | -0.10 |
基本平均股數(千股) | 131942.00 | 131808.00 | 134873.00 | 138917.00 | 142179.00 | 143051.00 | 143327.00 | 144013.00 | - | 142847.00 |
稀釋平均股數(千股) | 138160.00 | 136008.00 | 137526.00 | 138917.00 | 147675.00 | 145651.00 | 144110.00 | 144013.00 | - | 142847.00 |
還原基本每股稅後盈餘(元) | 1.60 | 0.24 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | - | -0.09 |
還原稀釋每股稅後盈餘(元) | 1.52 | 0.23 | 0.16 | 0.16 | 0.01 | 0.10 | 0.00 | -0.07 | -0.18 | -0.10 |
還原基本平均股數(千股) | 131,942 | 131,808 | 134,873 | 138,917 | 142,179 | 143,051 | 143,327 | 144,013 | - | 142,847 |
還原稀釋平均股數(千股) | 138,160 | 136,008 | 137,526 | 138,917 | 147,675 | 145,651 | 144,110 | 144,013 | - | 142,847 |
EBITDA(千元) | 39,266 | 35,301 | 25,574 | 27,616 | 4,202 | 17,487 | 4,394 | -7,086 | -23,462 | -9,724 |